Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
6 studies found for:    Open Studies | "Rickets, Hypophosphatemic"
Show Display Options
Rank Status Study
1 Unknown  Effect of Cinacalcet on Parathyroid Hormone Secretion in Children and Adolescents With Hypophosphatemic Rickets
Condition: Hypophosphatemic Rickets, X-Linked Dominant
Intervention: Drug: Cinacalcet
2 Recruiting Iron Therapy for Autosomal Dominant Hypophosphatemic Rickets: A Pilot Project.
Condition: Autosomal Dominant Hypophosphatemic Rickets
Intervention: Dietary Supplement: Iron
3 Recruiting A Study of KRN23 in Subjects With X-linked Hypophosphatemic Rickets/Osteomalacia
Condition: X-linked Hypophosphatemic Rickets/Osteomalacia
Intervention: Drug: KRN23
4 Recruiting Calcitonin for Treating X-linked Hypophosphatemia
Condition: Hypophosphatemic Rickets, X Linked Dominant
Interventions: Drug: nasal salmon calcitonin;   Drug: Saline Nasal Spray Placebo
5 Recruiting Cinacalcet for Fibroblast Growth Factor 23 (FGF23)-Mediated Hypophosphatemia (Hypophosphatemic Rickets)
Condition: Osteomalacia
Intervention: Drug: Osteomalacia
6 Recruiting Study of KRN23, a Recombinant Fully Human Monoclonal Antibody Against FGF23, in Pediatric Subjects With X-linked Hypophosphatemia (XLH)
Condition: X-linked Hypophosphatemia
Intervention: Drug: KRN23

Indicates status has not been verified in more than two years